Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... In the current study, researchers sought to use Bortezomib (Velcade®) against osteosarcoma, an aggressive cancer that starts in bone, spreads quickly and responds poorly to ...
2009 NOV 16 ... Researchers detail in 'Prognostic effect of diaphyseal location in osteosarcoma: a cohort case-control study at a single institute,' new data in...
2009 NOV 16 ... for the treatment of several malignant tumors, the impact of hyperbaric oxygen on osteosarcoma has not yet been demonstrated. In this study, we investigated the efficacy of hyperbaric ...
2009 NOV 16 ... According to a study from Kanazawa, Japan, "The prognosis for patients with metastatic osteosarcoma is still poor despite the development of effective adjuvant and neoadjuvant chemotherapy ...
2009 NOV 9 ... 1008 bp of the OPG 5'-flanking region to be sufficiently transcriptionally active in osteosarcoma cell lines and generated serial promoter deletion constructs. Individual subcloning ...
2009 NOV 24 ... researchers concluded: "The results of the MTT test showed that proliferation of human osteosarcoma cells on the composites was considerably better than that of pure ...
2009 NOV 16 ... age of 30.94 years." "There were 14 males. The most common diagnosis was osteosarcoma. The average follow-up period was 54.05 months with the longest being 168 months. The ...
2009 NOV 16 ... segment after recycling in liquid nitrogen." "Ten patients with osteosarcoma around the knee were included, with a mean age of 21 years. The operative technique ...
2009 NOV 16 ... According to a study from Tsu, Japan, "Osteosarcoma (OS) is the most common primary malignant tumor of the bone and often forms pulmonary ...
2009 NOV 16 ... prognostic biomarkers and signaling pathways that are common to both canine and human. Osteosarcoma (OS) accounts for approximately 80% of all malignant bone tumors in the dog." ...
2009 NOV 23 ... 'Innovative trident fixation technique for allograft knee arthrodesis for high-grade osteosarcoma around the knee.' According to a study from Taipei, Taiwan, "Reconstruction for...
2009 NOV 16 ... CP751,871. In vivo CP-751,871, rapamycin, or the combination were evaluated against EWS, osteosarcoma, and rhabdomyosarcoma xenografts. CP751871 induced significant growth inhibition ...
2009 NOV 23 ... New research, 'Up-regulation of osteolytic mediators in human osteosarcoma cells stimulated with nicotine,' is the subject of a report. According to a study from ...
2009 NOV 16 ... to investigate the role of Chk1 in unstressed conditions. Chk1 depletion in U2OS human osteosarcoma cells inhibited cell proliferation and raised the percentage of cells with a 4N DNA ...
2009 NOV 9 ... the repressive activity of BCL6 and increased the levels of apoptosis induced by BCL6 in osteosarcoma cells indicating that both proteins cooperate in vivo to cause a physiological affect. ...
2009 NOV 16 ... published the results of their research in Apmis (Anti-angiogenic factor endostatin in osteosarcoma. Apmis, 2009;117(10):716-723). For additional information, contact Y.K. ...
